The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Nightingale, John
    Company Director born in June 1945
    Individual (3 offsprings)
    Officer
    2017-08-02 ~ dissolved
    OF - Director → CIF 0
  • 2
    Boulton, Paul
    Accountant born in July 1959
    Individual (6 offsprings)
    Officer
    2017-01-24 ~ dissolved
    OF - Director → CIF 0
    Mr Paul Boulton
    Born in July 1959
    Individual (6 offsprings)
    Person with significant control
    2018-01-26 ~ dissolved
    PE - Has significant influence or controlCIF 0
Ceased 1
  • Mr Paul Boulton
    Born in July 1959
    Individual (6 offsprings)
    Person with significant control
    2017-01-24 ~ 2017-06-06
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    2017-06-06 ~ 2017-06-06
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

ARIERA PHARMA LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Debtors
474 GBP2021-01-31
1,228 GBP2020-01-31
Cash at bank and in hand
122,716 GBP2021-01-31
128,288 GBP2020-01-31
Current Assets
123,190 GBP2021-01-31
129,516 GBP2020-01-31
Creditors
Current, Amounts falling due within one year
-1,524 GBP2021-01-31
-8,524 GBP2020-01-31
Net Current Assets/Liabilities
121,666 GBP2021-01-31
120,992 GBP2020-01-31
Equity
Called up share capital
100,000 GBP2021-01-31
100,000 GBP2020-01-31
Retained earnings (accumulated losses)
21,666 GBP2021-01-31
20,992 GBP2020-01-31
Equity
121,666 GBP2021-01-31
120,992 GBP2020-01-31
Average Number of Employees
22020-02-01 ~ 2021-01-31
22019-02-01 ~ 2020-01-31
Other Debtors
Current
474 GBP2021-01-31
998 GBP2020-01-31
Prepayments/Accrued Income
Current
0 GBP2021-01-31
230 GBP2020-01-31
Debtors
Current, Amounts falling due within one year
474 GBP2021-01-31
1,228 GBP2020-01-31
Trade Creditors/Trade Payables
Current
0 GBP2021-01-31
2,730 GBP2020-01-31
Corporation Tax Payable
Current
158 GBP2021-01-31
4,269 GBP2020-01-31
Other Creditors
Current
43 GBP2021-01-31
0 GBP2020-01-31
Accrued Liabilities/Deferred Income
Current
1,323 GBP2021-01-31
1,525 GBP2020-01-31
Creditors
Current
1,524 GBP2021-01-31
8,524 GBP2020-01-31

  • ARIERA PHARMA LIMITED
    Info
    Registered number 10581699
    C/o Azets Secure House, Lulworth Close, Chandlers Ford, Southampton SO53 3TL
    Private Limited Company incorporated on 2017-01-24 and dissolved on 2023-05-28 (6 years 4 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.